Talphera, Inc. TLPH
1.05 USD -0.04 (-3.67%)
At closeNov 10, 2026, 7:15 PM EST
1.05 0.00 0.00%
After hours · Nov 10, 7:15 PM ET
1.05 Day range 1.14
0.69 52-week range 1.57
- YTD
- -7.89%
- 1 year
- -17.32%
News
prnewswire.com Talphera to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026 SAN MATEO, Calif., Nov. 4, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
defenseworld.net Head to Head Comparison: ANI Pharmaceuticals (NASDAQ:ANIP) and Talphera (NASDAQ:TLPH) Talphera (NASDAQ: TLPH - Get Free Report) and ANI Pharmaceuticals (NASDAQ: ANIP - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two…
zacks.com Talphera (TLPH) Upgraded to Buy: Here's What You Should Know Talphera (TLPH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
prnewswire.com Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference SAN MATEO, Calif., Sept. 3, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
seekingalpha.com Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript
benzinga.com Talphera Q2 EPS $(0.06) Beats $(0.07) Estimate Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 40 percent increase over losses of $(0.10) per…
prnewswire.com Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update NEPHRO CRRT clinical study of nafamostat is 75% enrolled; expected to be complete this year Draft 2026 KDIGO guidelines added nafamostat as an acceptable CRRT anticoagulant, a positive change from…
prnewswire.com Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026 SAN MATEO, Calif., Aug. 5, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com HC Wainwright & Co. Assumes Talphera at Buy, Announces Price Target of $3 HC Wainwright & Co. analyst Brandon Folkes assumes Talphera (NASDAQ:TLPH) with a Buy rating and announces Price Target of $3.
seekingalpha.com Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript
benzinga.com Talphera Q1 2026 Earnings Call Transcript 
benzinga.com Talphera Q1 EPS $(0.04) Beats $(0.07) Estimate, Sales $0.00 Down From $27.000K YoY Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 60 percent increase over losses of $(0.10) per…
prnewswire.com Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update NEPHRO CRRT clinical study expected to be completed this year Cash and investments of $21.1 million at March 31, 2026 Conference call and webcast to be held on Wednesday, May 13, 2026 at 4:30 pm ET…
benzinga.com Earnings Scheduled For May 13, 2026 
prnewswire.com Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 SAN MATEO, Calif., May 7, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies…- benzinga.com WestPark Capital Initiates Coverage On Talphera with Buy Rating, Announces Price Target of $3 WestPark Capital analyst Ed Arce initiates coverage on Talphera (NASDAQ:TLPH) with a Buy rating and announces Price Target of $3.
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 9 Health Care Stocks Moving In Wednesday's Pre-Market Session
prnewswire.com Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 SAN MATEO, Calif., March 25, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
defenseworld.net Talphera Q4 Earnings Call Highlights Talphera (NASDAQ: TLPH) used a virtual analyst and investor event to provide a business update and to highlight what company leaders and two clinical experts described as an unmet need in…
seekingalpha.com Talphera, Inc. (TLPH) Analyst/Investor Day Transcript Talphera, Inc. (TLPH) Analyst/Investor Day Transcript
benzinga.com Talphera Q4 EPS $(0.06) Beats $(0.14) Estimate Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.14) by 57.14 percent. This is a 14.29 percent increase over losses of $(0.07)…
prnewswire.com Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Previously announced achievement of 50% enrollment of the NEPHRO CRRT clinical study in March 2026 and closed the associated financing tranche of $4.1 million All 12 clinical study sites now able to…
prnewswire.com Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 SAN MATEO, Calif., March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…- benzinga.com Talphera Announces 50% Patient Enrollment Of NEPHRO-CRRT Clinical Trial Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new target profile sitesCompany to host a virtual investor and analyst event on March 23 at 11:00 am ET…
prnewswire.com Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new target profile sites Company to host a virtual investor and analyst event on March 23 at 11:00 am ET…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
defenseworld.net Talphera (NASDAQ:TLPH) Insider Purchases $28,350.00 in Stock Talphera, Inc. (NASDAQ: TLPH - Get Free Report) insider Badri Dasu purchased 35,000 shares of the business's stock in a transaction on Thursday, February 12th. The shares were purchased at an average…
defenseworld.net Insider Buying: Talphera (NASDAQ:TLPH) Insider Acquires $28,350.00 in Stock Talphera, Inc. (NASDAQ: TLPH - Get Free Report) insider Shakil Aslam purchased 35,000 shares of the company's stock in a transaction dated Thursday, February 12th. The stock was bought at an average…
defenseworld.net Insider Buying: Talphera (NASDAQ:TLPH) CFO Buys $36,450.00 in Stock Talphera, Inc. (NASDAQ: TLPH - Get Free Report) CFO Raffi Asadorian acquired 45,000 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at…
defenseworld.net Talphera (NASDAQ:TLPH) Shares Down 0.3% – Here’s What Happened Talphera, Inc. (NASDAQ: TLPH - Get Free Report)'s share price fell 0.3% on Thursday. The company traded as low as $0.7808 and last traded at $0.8079. 39,878 shares traded hands during trading, a…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Talphera Q3 EPS $(0.11) Beats $(0.13) Estimate, Sales $1.000K Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.13) by 12 percent. This is a 15.38 percent increase over losses of $(0.13) per…- benzinga.com Earnings Scheduled For November 12, 2025
benzinga.com Earnings Outlook For Talphera - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com Talphera Q2 EPS $(0.10) Beats $(0.12) Estimate Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 13.04 percent. This is a 33.33 percent increase over losses of $(0.15)…
benzinga.com Earnings Scheduled For August 14, 2025 
benzinga.com A Preview Of Talphera's Earnings - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com Talphera Q1 EPS $(0.10) Beats $(0.14) Estimate, Sales $27.00K Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.16) per…